← FDA DRUG APPROVALS

FDA ANDA · ANDA078402

LISINOPRIL

Sponsor: WOCKHARDT BIO AG

APPLICATION
ANDA078402
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-19
LATEST ACTION
2020-05-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

LISINOPRILPrescription
LISINOPRIL 30MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 10MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 2.5MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 40MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 20MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 5MG · TABLET · ORAL

Approval history

2020-05-13Labeling · Supplement 9 · standardAP
2016-03-24Labeling · Supplement 7 · standardAP
2016-03-24Labeling · Supplement 8 · standardAP
2015-01-15Labeling · Supplement 5AP
2014-12-22Labeling · Supplement 1AP
2007-04-19Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →